Pandemic's toll on cancer patients with neuropathy under the microscope

NCT ID NCT04650178

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at how the COVID-19 pandemic impacted the quality of life of 274 cancer patients who also have neuropathy (nerve pain). All participants had taken part in earlier clinical trials. Researchers want to see if there are differences between those who received a brain-training therapy called neurofeedback and those who did not. The goal is to learn how to better support patients during future health emergencies.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this study could help develop better programs and policies to support chronic pain patients during major health crises like a pandemic.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly improve health. Results are based on questionnaires and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.